Angela L Mazul1, James M Taylor2, Kimon Divaris1,3, Mark C Weissler2, Paul Brennan4, Devasena Anantharaman4, Behnoush Abedi-Ardekani4, Andrew F Olshan1,5, Jose P Zevallos1,2,5. 1. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 2. Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina. 3. Department of Pediatric Dentistry, University of North Carolina at Chapel Hill School of Dentistry, Chapel Hill, North Carolina. 4. International Agency for Research on Cancer, Lyon, France. 5. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Abstract
BACKGROUND: Indicators of poor oral health, including smoking, have been associated with increased risk of head and neck squamous cell carcinoma, especially oropharyngeal squamous cell carcinoma (OPSCC), yet few studies have examined whether this association is modified by human papillomavirus (HPV) status. METHODS: Data from interviews and tumor HPV status from a large population-based case-control study, the Carolina Head and Neck Cancer Study (CHANCE), were used to estimate the association between oral health indicators and smoking among 102 HPV-positive patients and 145 HPV-negative patients with OPSCC and 1396 controls. HPV status was determined by p16INK4a (p16) immunohistochemistry. Unconditional, multinomial logistic regression was used to estimate odds ratios (ORs) for all oral health indictors adjusting for important covariates. RESULTS: Routine dental examinations were associated with a decreased risk of both HPV-negative OPSCC (OR, 0.52; 95% confidence interval [CI], 0.35-0.76) and HPV-positive OPSCC (OR, 0.55; 95% CI, 0.36-.86). Tooth mobility (a proxy for periodontal disease) increased the risk of HPV-negative disease (OR, 1.70; 95% CI, 1.18-2.43) slightly more than the risk for HPV-positive disease (OR, 1.45; 95% CI, 0.95-2.20). Ten or more pack-years of cigarette smoking were strongly associated with an increased risk of HPV-negative OPSCC (OR, 4.26; 95% CI, 2.85-6.37) and were associated less with an increased risk of HPV-positive OPSCC (OR, 1.62; 95% CI, 1.10-2.38). CONCLUSIONS: Although HPV-positive and HPV-negative HNSCC differ significantly with respect to etiology and tumorigenesis, the current findings suggest a similar pattern of association between poor oral health, frequency of dental examinations, and both HPV-positive and HPV-negative OPSCC. Future research is required to elucidate interactions between poor oral health, tobacco use, and HPV in the development of OPSCC. Cancer 2017;71-80.
BACKGROUND: Indicators of poor oral health, including smoking, have been associated with increased risk of head and neck squamous cell carcinoma, especially oropharyngeal squamous cell carcinoma (OPSCC), yet few studies have examined whether this association is modified by human papillomavirus (HPV) status. METHODS: Data from interviews and tumorHPV status from a large population-based case-control study, the Carolina Head and Neck Cancer Study (CHANCE), were used to estimate the association between oral health indicators and smoking among 102 HPV-positive patients and 145 HPV-negative patients with OPSCC and 1396 controls. HPV status was determined by p16INK4a (p16) immunohistochemistry. Unconditional, multinomial logistic regression was used to estimate odds ratios (ORs) for all oral health indictors adjusting for important covariates. RESULTS: Routine dental examinations were associated with a decreased risk of both HPV-negative OPSCC (OR, 0.52; 95% confidence interval [CI], 0.35-0.76) and HPV-positive OPSCC (OR, 0.55; 95% CI, 0.36-.86). Tooth mobility (a proxy for periodontal disease) increased the risk of HPV-negative disease (OR, 1.70; 95% CI, 1.18-2.43) slightly more than the risk for HPV-positive disease (OR, 1.45; 95% CI, 0.95-2.20). Ten or more pack-years of cigarette smoking were strongly associated with an increased risk of HPV-negative OPSCC (OR, 4.26; 95% CI, 2.85-6.37) and were associated less with an increased risk of HPV-positive OPSCC (OR, 1.62; 95% CI, 1.10-2.38). CONCLUSIONS: Although HPV-positive and HPV-negative HNSCC differ significantly with respect to etiology and tumorigenesis, the current findings suggest a similar pattern of association between poor oral health, frequency of dental examinations, and both HPV-positive and HPV-negative OPSCC. Future research is required to elucidate interactions between poor oral health, tobacco use, and HPV in the development of OPSCC. Cancer 2017;71-80.
Authors: Neela Guha; Paolo Boffetta; Victor Wünsch Filho; Jose Eluf Neto; Oxana Shangina; David Zaridze; Maria Paula Curado; Sergio Koifman; Elena Matos; Ana Menezes; Neonila Szeszenia-Dabrowska; Leticia Fernandez; Dana Mates; Alexander W Daudt; Jolanta Lissowska; Rajesh Dikshit; Paul Brennan Journal: Am J Epidemiol Date: 2007-08-30 Impact factor: 4.897
Authors: Margaret M Madeleine; Tarja Anttila; Stephen M Schwartz; Pekka Saikku; Maija Leinonen; Joseph J Carter; Michelle Wurscher; Lisa G Johnson; Denise A Galloway; Janet R Daling Journal: Int J Cancer Date: 2007-02-01 Impact factor: 7.396
Authors: David I Conway; Mark Petticrew; Helen Marlborough; Julien Berthiller; Mia Hashibe; Lorna M D Macpherson Journal: Int J Cancer Date: 2008-06-15 Impact factor: 7.396
Authors: K K Oguejiofor; J S Hall; N Mani; C Douglas; N J Slevin; J Homer; G Hall; C M L West Journal: Clin Oncol (R Coll Radiol) Date: 2013-07-31 Impact factor: 4.126
Authors: Mine Tezal; Maureen A Sullivan; Mary E Reid; James R Marshall; Andrew Hyland; Thom Loree; Cheryl Lillis; Linda Hauck; Jean Wactawski-Wende; Frank A Scannapieco Journal: Arch Otolaryngol Head Neck Surg Date: 2007-05
Authors: Melissa N Eliot; Dominique S Michaud; Scott M Langevin; Michael D McClean; Karl T Kelsey Journal: Cancer Causes Control Date: 2013-04-09 Impact factor: 2.506
Authors: Maximilian Moergel; Peer Kämmerer; Adrian Kasaj; Evangelia Armouti; Abdulmonem Alshihri; Veronika Weyer; Bilal Al-Nawas Journal: Head Face Med Date: 2013-12-09 Impact factor: 2.151
Authors: Douglas R Farquhar; Kimon Divaris; Angela L Mazul; Mark C Weissler; Jose P Zevallos; Andrew F Olshan Journal: Oral Oncol Date: 2017-10 Impact factor: 5.337
Authors: Nicholas R Lenze; Douglas Farquhar; Siddharth Sheth; Jose P Zevallos; Jeffrey Blumberg; Catherine Lumley; Samip Patel; Trevor Hackman; Mark C Weissler; Wendell G Yarbrough; Adam M Zanation; Andrew F Olshan Journal: Laryngoscope Date: 2020-11-10 Impact factor: 3.325
Authors: F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi Journal: Acta Otorhinolaryngol Ital Date: 2018-04 Impact factor: 2.124
Authors: Marc A Emerson; Douglas R Farquhar; Nicholas R Lenze; Siddharth Sheth; Angela L Mazul; Adam M Zanation; Trevor G Hackman; Mark C Weissler; Jose P Zevallos; Wendell G Yarbrough; Paul Brennan; Behnoush Abedi-Ardekani; Andrew F Olshan Journal: Head Neck Date: 2022-01-19 Impact factor: 3.147
Authors: Jason Tasoulas; Nicholas R Lenze; Douglas Farquhar; Travis P Schrank; Colette Shen; M Ali Shazib; Bart Singer; Shetal Patel; Juneko E Grilley Olson; David N Hayes; Margaret L Gulley; Bhishamjit S Chera; Trevor Hackman; Andrew F Olshan; Jared Weiss; Siddharth Sheth Journal: Cancer Med Date: 2021-05-02 Impact factor: 4.452
Authors: Nicholas R Lenze; Douglas R Farquhar; Siddharth Sheth; Jose P Zevallos; Catherine Lumley; Jeffrey Blumberg; Samip Patel; Trevor Hackman; Mark C Weissler; Wendell G Yarbrough; Andrew F Olshan; Adam M Zanation Journal: Oral Oncol Date: 2021-06-20 Impact factor: 5.972